{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T07:19:30Z","timestamp":1781421570605,"version":"3.54.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Psychiatry Rep"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1007\/s11920-004-0076-y","type":"journal-article","created":{"date-parts":[[2007,6,2]],"date-time":"2007-06-02T12:17:25Z","timestamp":1180786645000},"page":"268-273","source":"Crossref","is-referenced-by-count":21,"title":["Integrating pharmacotherapy and psychotherapy in the management of anxiety disorders"],"prefix":"10.1007","volume":"6","author":[{"given":"John M.","family":"Kuzma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald W.","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"76_CR1","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/(SICI)1522-7154(1996)2:4<167::AID-ANXI2>3.0.CO;2-L","volume":"2","author":"RL Dupont","year":"1996","unstructured":"Dupont RL, Rice DP, Miller LS, et al.: Economic costs of anxiety disorders. Anxiety 1996, 2:167\u2013172.","journal-title":"Anxiety"},{"key":"76_CR2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890423349","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2000","unstructured":"American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, edn 4. Washington, DC: American Psychiatric Publishing; 2000.","edition":"edn 4"},{"key":"76_CR3","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9781615377138","volume-title":"Clinical Manual of Anxiety Disorders","author":"DJ Stein","year":"2004","unstructured":"Stein DJ: Clinical Manual of Anxiety Disorders. Washington, DC: American Psychiatric Publishing; 2004."},{"key":"76_CR4","first-page":"543","volume-title":"Textbook of Psychiatry","author":"E Hollander","year":"2003","unstructured":"Hollander E, Simeon D: Anxiety disorders. In Textbook of Psychiatry, edn 4. Edited by Hales RE, Yudofsky SC, Talbott JA. Washington, DC: American Psychiatric Press; 2003:543\u2013630.","edition":"edn 4"},{"key":"76_CR5","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1097\/00005053-199009000-00003","volume":"178","author":"RP Mattick","year":"1990","unstructured":"Mattick RP, Andrews G, Hadzi-Pavolic D, et al.: Treatment of panic and agoraphobia: an integrative review. J Nerv Ment Dis 1990, 178:567\u2013576.","journal-title":"J Nerv Ment Dis"},{"key":"76_CR6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1001\/archpsyc.1983.01790020019002","volume":"40","author":"CM Zitrin","year":"1980","unstructured":"Zitrin CM, Klein DF, Woerner MG, et al.: Treatment of phobias I: comparison of imipramine hydrochloride and placebo. Arch Gen Psychiatry 1980, 40:125\u2013138. Although from 1980, this is a landmark study that helped open the current debate.","journal-title":"Arch Gen Psychiatry"},{"key":"76_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1176\/ajp.155.12.1799","volume":"155","author":"J Gorman","year":"1998","unstructured":"Gorman J, Shear K, March J, et al.: Practice guidelines for the treatment of patients with panic disorder. Am J Psychiatry 1998, 155(suppl):1\u201328.","journal-title":"Am J Psychiatry"},{"key":"76_CR8","first-page":"349","volume":"57","author":"RJ Noyes","year":"1996","unstructured":"Noyes RJ, Burrows GD, Reich JH, et al.: Diazepam versus alprazolam for the treatment of panic disorder. J Clin Psychiatry 1996, 57:349\u2013355. This is an interesting example of how study findings are incorporated into clinical practice.","journal-title":"J Clin Psychiatry"},{"key":"76_CR9","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S0006-3223(02)01552-4","volume":"52","author":"EB Foa","year":"2002","unstructured":"Foa EB, Franklin ME, Moser J: Context in clinic: how well do cognitive-behavioral therapies and medications work in combination? Biol Psychiatry 2002, 52:987\u2013997. This is a comprehensive and articulate review.","journal-title":"Biol Psychiatry"},{"key":"76_CR10","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1001\/jama.283.19.2529","volume":"283","author":"DH Barlow","year":"2000","unstructured":"Barlow DH, Gorman JM, Shear MK, et al.: Cognitive-behavioral therapy, imipramine or their combination for panic disorder. JAMA 2000, 283:2529\u20132536.","journal-title":"JAMA"},{"key":"76_CR11","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0272-7358(97)00084-6","volume":"18","author":"HA Westra","year":"1998","unstructured":"Westra HA, Stewart SH: Cognitive-behavioral therapy and pharmacotherapy: complementary or contradictory approaches to the treatment of anxiety. Clin Psychol Rev 1998, 18:307\u2013340.","journal-title":"Clin Psychol Rev"},{"key":"76_CR12","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S0005-7894(96)80028-1","volume":"27","author":"MW Otto","year":"1996","unstructured":"Otto MW, Pollack MH, Sabatino SA: Maintenance and remission following cognitive-behavior therapy for panic disorder: possible deleterious effects of concurrent medication treatment. Behav Ther 1996, 27:473\u2013482.","journal-title":"Behav Ther"},{"key":"76_CR13","first-page":"A4","volume":"59","author":"JF Rosenbaum","year":"1995","unstructured":"Rosenbaum JF, Pollock RA, Otto MA, et al.: Integrated treatment of panic disorder. Bull Menninger Clin 1995, 59(suppl):A4-A26.","journal-title":"Bull Menninger Clin"},{"key":"76_CR14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4088\/JCP.v63n0103","volume":"63","author":"K Rickles","year":"2002","unstructured":"Rickles K, Rynn M: Pharmacotherapy of generalized anxiety disorder. J Clin Psychiatry 2002, 63(suppl):9\u201316.","journal-title":"J Clin Psychiatry"},{"key":"76_CR15","first-page":"53","volume":"62","author":"JC Ballenger","year":"2001","unstructured":"Ballenger JC, Davidson JRT, Lecrubier Y, et al.: Consensus statement on generalized anxiety disorder from the international consensus group on depression and anxiety. J Clin Psychiatry 2001, 62(suppl):53\u201358.","journal-title":"J Clin Psychiatry"},{"key":"76_CR16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/0887-6185(90)90026-6","volume":"4","author":"KG Power","year":"1990","unstructured":"Power KG, Simpson MB, Swanson V, et al.: A controlled comparison of cognitive-behavioral therapy, diazepam, and placebo in the management of generalized anxiety disorder. J Anxiety Disord 1990, 4:267\u2013292.","journal-title":"J Anxiety Disord"},{"key":"76_CR17","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0165-0327(01)00469-4","volume":"72","author":"AJ Bond","year":"2002","unstructured":"Bond AJ, Wingrove J, Curran HJ, et al.: Treatment of generalized anxiety disorder with a short course of psychological therapy, combined with buspirone or placebo. J Affect Disord 2002, 72:267\u2013271.","journal-title":"J Affect Disord"},{"key":"76_CR18","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1176\/ajp.154.7.911","volume":"154","author":"JF Leckman","year":"1997","unstructured":"Leckman JF, Grice DE, Boardman J, et al.: Symptoms of generalized anxiety disorder. Am J Psychiatry 1997, 154:911\u2013917.","journal-title":"Am J Psychiatry"},{"key":"76_CR19","first-page":"7","volume":"58","author":"Y Sasson","year":"1997","unstructured":"Sasson Y, Zohar J, Chopra M, et al.: Epidemiology of obsessive compulsive disorder: a world view. J Clin Psychiatry 1997, 58(suppl):7\u201310.","journal-title":"J Clin Psychiatry"},{"key":"76_CR20","first-page":"5","volume":"58","author":"JS March","year":"1997","unstructured":"March JS, Frances A, Carpenter D, et al.: The expert consensus series: treatment of obsessive-compulsive disorder. J Clin Psychiatry 1997, 58(suppl):5\u201328.","journal-title":"J Clin Psychiatry"},{"key":"76_CR21","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.4088\/JCP.v63n1108","volume":"63","author":"U Albert","year":"2002","unstructured":"Albert U, Aguglia E, Maina G, et al.: Venlafaxine versus clomipramine in the treatment of obsessive-compulsive disorder: a preliminary single-blind, 12-week, controlled study. J Clin Psychiatry 2002, 63:1004\u20131009.","journal-title":"J Clin Psychiatry"},{"key":"76_CR22","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1001\/archpsyc.57.8.794","volume":"57","author":"CJ McDougle","year":"2000","unstructured":"McDougle CJ, Goodman WK, Leckman JF, et al.: A doubleblind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. Arch Gen Psychiatry 2000, 57:794\u2013801.","journal-title":"Arch Gen Psychiatry"},{"key":"76_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/00004850-199001000-00002","volume":"5","author":"J Cottraux","year":"1990","unstructured":"Cottraux J, Mollard E, Bouvard M, et al.: A controlled study of fluvoxamine and exposure in obsessive-compulsive disorder. Int Clin Psychopharmacology 1990, 5:17\u201330.","journal-title":"Int Clin Psychopharmacology"},{"key":"76_CR24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1192\/S0007125000297924","volume":"173","author":"F Hohagen","year":"1998","unstructured":"Hohagen F, Winkelman G, Rasche-Rauchle H, et al.: Combination of behavior therapy with fluvoxamine in comparison with behavior therapy and placebo. Br J Psychiatry 1998, 173(suppl):71\u201378.","journal-title":"Br J Psychiatry"},{"key":"76_CR25","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1097\/00005053-199808000-00007","volume":"186","author":"AJ van Balkom","year":"1998","unstructured":"van Balkom AJ, de Haan E, van Oppen P, et al.: Cognitive and behavioral therapies alone and in combination with fluvoxamine in the treatment of obsessive-compulsive disorder. J Nerv Ment Dis 1998, 186:492\u2013499.","journal-title":"J Nerv Ment Dis"},{"key":"76_CR26","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1176\/appi.ajp.158.2.275","volume":"158","author":"MA Van Ameringen","year":"2001","unstructured":"Van Ameringen MA, Lane RM, Walker JR, et al.: Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study. Am J Psychiatry 2001, 158:275\u2013281.","journal-title":"Am J Psychiatry"},{"key":"76_CR27","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1176\/ajp.156.11.1814","volume":"156","author":"JD Lipsitz","year":"1999","unstructured":"Lipsitz JD, Markowitz JC, Cherry S, et al.: Open trial of interpersonal psychotherapy for the treatment of social phobia. Am J Psychiatry 1999, 156:1814\u20131816.","journal-title":"Am J Psychiatry"},{"key":"76_CR28","first-page":"A3","volume":"56","author":"GO Gabbard","year":"1992","unstructured":"Gabbard GO: Psychodynamics of panic disorder and social phobia. Bull Menninger Clin 1992, 56(suppl):A3-A13.","journal-title":"Bull Menninger Clin"},{"key":"76_CR29","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1001\/archpsyc.55.12.1133","volume":"55","author":"RG Heimberg","year":"1998","unstructured":"Heimberg RG, Liebowitz MR, Hope DA, et al.: Cognitivebehavioral group treatment of social phobia: 12-week outcome. Arch Gen Psychiatry 1998, 55:1133\u20131141.","journal-title":"Arch Gen Psychiatry"},{"key":"76_CR30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1192\/bjp.179.1.23","volume":"179","author":"S Blomhoff","year":"2001","unstructured":"Blomhoff S, Haug TT, Hellstrom K, et al.: Randomised controlled general practice trial of sertraline, exposure therapy, and combined treatment in generalized social phobia. Br J Psychiatry 2001, 179:23\u201330.","journal-title":"Br J Psychiatry"},{"key":"76_CR31","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1001\/archpsyc.1995.03950240066012","volume":"52","author":"RC Kessler","year":"1995","unstructured":"Kessler RC, Sonnega A, Bromet E, et al.: Posttraumatic stress disorder in the national comorbidity survey. Arch Gen Psychiatry 1995, 52:1048\u20131060.","journal-title":"Arch Gen Psychiatry"},{"key":"76_CR32","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1176\/ajp.153.6.771","volume":"153","author":"DR Johnson","year":"1996","unstructured":"Johnson DR, Rosenheck R, Fontana A, et al.: Outcome of intensive inpatient treatment for combat-related posttraumatic stress disorder. Am J Psychiatry 1996, 153:771\u2013777.","journal-title":"Am J Psychiatry"},{"key":"76_CR33","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1001\/archpsyc.60.5.481","volume":"60","author":"PP Schnurr","year":"2003","unstructured":"Schnurr PP, Friedman MJ, Foy D: Randomized trial of traumafocused group therapy for posttraumatic stress disorder. Arch Gen Psychiatry 2003, 60:481\u2013489.","journal-title":"Arch Gen Psychiatry"},{"key":"76_CR34","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1176\/appi.psychotherapy.2003.57.3.374","volume":"57","author":"RD Marshall","year":"2003","unstructured":"Marshall RD, Carcamo JH, Blanco C, et al.: Trauma-focused psychotherapy after a partial response to medication in PTSD: pilot observations. Am J Psychother 2003, 57:374\u2013383.","journal-title":"Am J Psychother"},{"key":"76_CR35","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/S0005-7967(03)00032-9","volume":"41","author":"MW Otto","year":"2003","unstructured":"Otto MW, Hinton D, Korbly NB, et al.: Treatment of pharmacotherapy-refractory posttraumatic stress disorder among Cambodian refugees: a pilot study of combination treatment with cognitive-behavior therapy vs sertraline alone. Behav Res Ther 2003, 41:1271\u20131276.","journal-title":"Behav Res Ther"}],"container-title":["Current Psychiatry Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-004-0076-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11920-004-0076-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-004-0076-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-004-0076-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T21:39:17Z","timestamp":1737063557000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11920-004-0076-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["76"],"URL":"https:\/\/doi.org\/10.1007\/s11920-004-0076-y","relation":{},"ISSN":["1523-3812","1535-1645"],"issn-type":[{"value":"1523-3812","type":"print"},{"value":"1535-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}